Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients
NCT ID: NCT01414322
Last Updated: 2011-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
45 participants
OBSERVATIONAL
2011-09-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing
NCT01452945
Study the Diagnostic and Therapeutic Role of Flexible Bronchoscopy in the Patients Attending Assuit University Children Hospita
NCT07043309
Wheeze Detection Using Aevice Medical Device
NCT05194436
Clinical, Airway Inflammatory, and HRA Phenotypes, in Preschool Children With Acute Asthmatic Attack Presenting to the ED.
NCT01175174
The Nature of Reflux-respiratory Symptoms Association in Difficult to Treat Wheezing\Coughing Babies
NCT00512382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Patients ages 0 - 3
No interventions assigned to this group
Group 2: Patients ages 3 - 7
No interventions assigned to this group
Group 3: Patients ages 7 - 15
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient management is according to standardized protocols used in Hadassah Mt. Scopus pediatric emergency department including:
* asthma management protocol
* bronchiolitis management protocol
* ages 0 - 15
* patient's parent/guardian is able to comprehend and give informed consent for participating in the study
Exclusion Criteria
* patient has received oral or IV steroids in a time window of 30 minutes to 5 hours prior to enrollment
* ventilated patients, while ventilated
* chest skin lesions
* cystic fibrosis
* hemodynamic instability
* patient's parent/guardian objects to the study protocol
* concurrent participation in any other clinical study
* physician objection
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
KarmelSonix Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KarmelSonix Ltd.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eitan Kerem, Prof.
Role: PRINCIPAL_INVESTIGATOR
Hadassah Medical Center Mt. Scopus, Jerusalem, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Center Mt. Scopus
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSI-IL-HHZ-ER-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.